<--- Back to Details
First PageDocument Content
Chemical pathology / Clinical pathology / Coagulation system / Medical laboratory scientist / Clinical Laboratory Improvement Amendments / Venipuncture / Medical laboratory / Linux From Scratch / Medicine / Pathology / Hematology
Date: 2014-06-18 17:31:35
Chemical pathology
Clinical pathology
Coagulation system
Medical laboratory scientist
Clinical Laboratory Improvement Amendments
Venipuncture
Medical laboratory
Linux From Scratch
Medicine
Pathology
Hematology

Clinical Laboratory Technology Advisory Committee

Add to Reading List

Source URL: www.cdph.ca.gov

Download Document from Source Website

File Size: 35,99 KB

Share Document on Facebook

Similar Documents

Blood / Medicine / Anatomy / Transfusion medicine / Hematology / Blood products / Coagulation system / Platelet / Blood transfusion / Hematocrit / Bleeding / Blood type

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Cell biology / Biology / Blood / Programmed cell death / Apoptosis / Coagulation system / Cell signaling / Induced stem cells / Caspase / Platelet / Thrombopoiesis / Angiogenesis

Microsoft Wordfile00

DocID: 1r9dZ - View Document

Blood / Coagulation system / Anatomy / CSL Behring / Von Willebrand disease / Factor VIII / Coagulation / CSL Limited / Hereditary angioedema / Haemophilia / Factor IX / Factor VII

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

Medicine / Coagulation system / Thrombin / Antibody / Syringe / Surgical suture / Draft:Professor Dr. S Tsakas II

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Finance / Money / Economy / Transfusion medicine / Blood products / Corporate finance / Venture capital / Coagulation system / Platelet / Nesta / Bleeding / Seed money

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document